T. Rowe Price Associates’s OmniAb OABI Stock Holding History
Bought
Maintained
Sold
Other funds holding OABI
WCM
CCM
RHJA
PMG
T. Rowe Price Associates's OABI Position: Q2 2026 in Review
T. Rowe Price Associates increased its OmniAb (OABI) stake by 4% in Q2 2026, buying an estimated $6.09K and bringing the position to 80,106 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.
T. Rowe Price Associates first reported a position in OABI in Q4 2022 and has held it in 15 quarters since. 131 funds tracked by Wall St. Rank hold OABI as of Q2 2026.
- T. Rowe Price Associates held 80,106 shares of OmniAb worth $198K as of Q2 2026.
- T. Rowe Price Associates bought 3,066 OmniAb shares in Q2 2026, an estimated $6.09K.
- OmniAb made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3012 holding.
- T. Rowe Price Associates first reported a position in OmniAb in Q4 2022 and has held it in 15 quarters since.
- 131 funds tracked by Wall St. Rank held OmniAb as of Q2 2026.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.